METIRRA Trademark

Trademark Overview

On Wednesday, July 9, 2025, a trademark application was filed for METIRRA with the United States Patent and Trademark Office. The USPTO has given the METIRRA trademark a serial number of 79432839. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Thursday, January 29, 2026. This trademark is owned by Envision Sciences Pty Ltd. The METIRRA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medicines; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances; biological preparations and substances for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes; biotechnological preparations for medical use; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeutics; biosimilars; immunotherapeutic agents for cancer; biomarkers and antibod...

Diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; disease diagnosis services; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; healthcare consultancy services [medical services]; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; pathology services; oncology (medical services); services for the preparation of medical reports; information, advisory and consultancy services in relation to the aforementioned
metirra

General Information

Serial Number79432839
Word MarkMETIRRA
Filing DateWednesday, July 9, 2025
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateThursday, January 29, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedicines; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances; biological preparations and substances for medical use; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes; biotechnological preparations for medical use; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeutics; biosimilars; immunotherapeutic agents for cancer; biomarkers and antibodies used in medical imaging
Goods and ServicesDiagnosis of diseases; medical analysis for the diagnosis and treatment of persons; disease diagnosis services; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; healthcare consultancy services [medical services]; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; pathology services; oncology (medical services); services for the preparation of medical reports; information, advisory and consultancy services in relation to the aforementioned

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 26, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMetirra Pty Ltd
Party Type11 - New Owner Before Publication
Legal Entity Type81 - NOT AVAILABLE
AddressAU
Party NameEnvision Sciences Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressAU

Trademark Events

Event DateEvent Description
Thursday, September 18, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 26, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 22, 2026CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, January 28, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 28, 2026APPLICATION FILING RECEIPT MAILED
Thursday, January 29, 2026ASSIGNED TO EXAMINER
Thursday, January 29, 2026NON-FINAL ACTION WRITTEN
Friday, January 30, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Related Keywords

metirra medical services diagnostic diagnosis biomarkers analysis cancer treatment preparations purposes